Literature DB >> 32419966

Methylglyoxal-derived advanced glycation end products induce matrix metalloproteinases through activation of ERK/JNK/NF-κB pathway in kidney proximal epithelial cells.

So-Ra Jeong1, Ho-Young Park2, Yoonsook Kim2, Kwang-Won Lee1.   

Abstract

The accumulation of reactive α-dicarbonyl leading to advanced glycation end products (AGEs) have been linked to pathophysiological diseases in many studies, such as atherosclerosis, cataract, cancer, and diabetic nephropathy. Glycation-generated AGEs increase the expression of inflammatory cytokines by transferring signals to the cell by binding them to the receptor for AGEs (RAGE) on their cell surface. The effect of methylglyoxal-derived AGEs (AGE-4) on the induction of matrix metalloproteinases (MMPs) in rat ordinary kidney cells (NRK-52E) was explored in this research, among other AGEs. The cell treated with 100 μg/mL AGE-4 for 24 h showed a substantial rise in MMP-2 and MMP-9 expression relative to BSA control only and other AGEs through ERK, JNK, and NF-B pathways. Our findings therefore suggest that AGE-4 expresses MMPs through the AGE-4-RAGE axis, activating MAPK signals that may contribute to dysfunction of the kidney cell. © The Korean Society of Food Science and Technology 2019.

Entities:  

Keywords:  Advanced glycation end products; Diabetic nephropathy; MAPK; Matrix metalloproteinase; NF-κB

Year:  2019        PMID: 32419966      PMCID: PMC7221093          DOI: 10.1007/s10068-019-00704-7

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  32 in total

1.  Methylglyoxal and Advanced Glycation End Products in Patients with Diabetes - What We Know so Far and the Missing Links.

Authors:  Jan Benedikt Groener; Dimitrios Oikonomou; Ruan Cheko; Zoltan Kender; Johanna Zemva; Lars Kihm; Martina Muckenthaler; Verena Peters; Thomas Fleming; Stefan Kopf; Peter P Nawroth
Journal:  Exp Clin Endocrinol Diabetes       Date:  2017-04-13       Impact factor: 2.949

2.  Protective Effects of Maillard Reaction Products of Whey Protein Concentrate against Oxidative Stress through an Nrf2-Dependent Pathway in HepG2 Cells.

Authors:  Min Cheol Pyo; Sung-Yong Yang; Su-Hyun Chun; Nam Su Oh; Kwang-Won Lee
Journal:  Biol Pharm Bull       Date:  2016-06-18       Impact factor: 2.233

Review 3.  Extracellular matrix metabolism in diabetic nephropathy.

Authors:  Roger M Mason; Nadia Abdel Wahab
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

4.  Immune enhancing effect of a Maillard-type lysozyme-galactomannan conjugate via signaling pathways.

Authors:  Young-min Ha; Su-Hyun Chun; Seung-taek Hong; Yun-chang Koo; Hee-don Choi; Kwang-won Lee
Journal:  Int J Biol Macromol       Date:  2013-06-17       Impact factor: 6.953

5.  Advanced glycation end products and diabetic nephropathy: a comparative study using diabetic and normal rats with methylglyoxal-induced glycation.

Authors:  Lisa Rodrigues; Paulo Matafome; Joana Crisóstomo; Daniela Santos-Silva; Cristina Sena; Paulo Pereira; Raquel Seiça
Journal:  J Physiol Biochem       Date:  2013-09-28       Impact factor: 4.158

6.  Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.

Authors:  M Takeuchi; Z Makita; R Bucala; T Suzuki; T Koike; Y Kameda
Journal:  Mol Med       Date:  2000-02       Impact factor: 6.354

Review 7.  Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

Authors:  Helen Vlassara; Jaime Uribarri
Journal:  Curr Diab Rep       Date:  2014-01       Impact factor: 4.810

Review 8.  A glimpse of matrix metalloproteinases in diabetic nephropathy.

Authors:  X Xu; L Xiao; P Xiao; S Yang; G Chen; F Liu; Y S Kanwar; L Sun
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

9.  Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.

Authors:  Ellena Linden; Weijing Cai; John C He; Chen Xue; Zhu Li; Jonathan Winston; Helen Vlassara; Jaime Uribarri
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 8.237

10.  Rapid preparation of high-purity nuclear proteins from a small number of cultured cells for use in electrophoretic mobility shift assays.

Authors:  Yuqian Luo; Takeshi Hara; Yuko Ishido; Aya Yoshihara; Kenzaburo Oda; Masahiko Makino; Norihisa Ishii; Naoki Hiroi; Koichi Suzuki
Journal:  BMC Immunol       Date:  2014-12-20       Impact factor: 3.615

View more
  4 in total

1.  Levilactobacillus brevis KU15151 Inhibits Staphylococcus aureus Lipoteichoic Acid-Induced Inflammation in RAW 264.7 Macrophages.

Authors:  Won-Ju Kim; Hyung-Seok Yu; Na-Kyoung Lee; Hyun-Dong Paik
Journal:  Probiotics Antimicrob Proteins       Date:  2022-05-13       Impact factor: 4.609

Review 2.  Roles, molecular mechanisms, and signaling pathways of TMEMs in neurological diseases.

Authors:  Qinghong Chen; Junlin Fang; Hui Shen; Liping Chen; Mengying Shi; Xianbao Huang; Zhiwei Miao; Yating Gong
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  Targeted therapy of cognitive deficits in fragile X syndrome.

Authors:  A Puścian; M Winiarski; J Borowska; S Łęski; T Górkiewicz; M Chaturvedi; K Nowicka; M Wołyniak; J J Chmielewska; T Nikolaev; K Meyza; M Dziembowska; L Kaczmarek; E Knapska
Journal:  Mol Psychiatry       Date:  2022-03-30       Impact factor: 13.437

4.  Activation of Nrf2 by Esculetin Mitigates Inflammatory Responses through Suppression of NF-κB Signaling Cascade in RAW 264.7 Cells.

Authors:  Thanasekaran Jayakumar; Chun-Jen Huang; Ting-Lin Yen; Chih-Wei Hsia; Joen-Rong Sheu; Periyakali Saravana Bhavan; Wei-Chieh Huang; Cheng-Ying Hsieh; Chih-Hsuan Hsia
Journal:  Molecules       Date:  2022-08-12       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.